FYU-981

· Fuji Yakuhin Co., Ltd.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for FYU-981, covering 2015-01-26 to 2018-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 3]